Seeking Alpha
 

Orthofix International N.V. (OFIX)

- NASDAQ
  • Wed, Apr. 29, 4:27 PM
    | Comment!
  • Tue, Mar. 31, 7:11 AM
    • Orthofix (OFIX +2.8%) FQ3 results: Revenues: $101M (+10.0%); COGS: $25.3M (+0.8%); R&D Expense: $6.6M (+3.1%); SG&A: $59.8M (+15.0%); Operating Income: $6.5M (+146.1%); Net Income: $28K (+100.2%); EPS: $0.00; Quick Assets: $29.8M (3.1%).
    • No guidance given.
    | Comment!
  • Tue, Mar. 31, 6:36 AM
    | Comment!
  • Aug. 6, 2014, 11:23 AM
    • Citing the potential need to restate previous restatement entries, Orthofix (OFIX -0.2%delays its quarterly earnings announcement pending the full analysis of the potential technical errors.
    • On a preliminary basis, it reports Q2 net sales of $101.3M, Biostem sales of $39.8M, Biologics sales of $13.9M, Extremity Fixation sales of $27.3M and Spine Fixation sales of $20.2M.
    | Comment!
  • May. 7, 2014, 6:40 PM
    | Comment!
  • Mar. 27, 2014, 6:16 AM
    • Orthofix International (OFIX): Q4 EPS of -$0.12
    • Revenue of $106.1M (-9.7% Y/Y) beats by $1.03M.
    • Press Release
    | Comment!
  • May. 9, 2013, 9:03 AM
    Orthofix (OFIX) slides 15% premarket after badly missing Q1 EPS and revenue expectations Wednesday evening. The company didn't help its cause by lowering its Q2 revenue guidance, saying it sees sales coming in at $104-107M, short of consensus which sits at $119.73M. (PR)
    | Comment!
  • May. 8, 2013, 4:58 PM
    Orthofix (OFIX): Q1 EPS of $0.23 misses by $0.43. Revenue of $100.3M (-14% Y/Y) misses by $10.92M. Shares -8% AH. (PR)
    | Comment!
  • Feb. 21, 2013, 5:17 PM
    Orthofix (OFIX): Q4 EPS of $0.81 beats by $0.01. Revenue of $112M misses by $5.47M. (PR)
    | Comment!
  • Oct. 24, 2012, 5:46 PM
    Orthofix International (OFIX): Q3 EPS of $0.76 beats by $0.02. Revenue of $114.8M (-2% Y/Y) misses by $6M. (PR)
    | Comment!
  • Jul. 26, 2012, 7:06 PM
    Orthofix International (OFIX): Q2 EPS of $0.78 may not be comparable to consensus of $0.72. Revenue of $119.5M (+2.4% Y/Y). (PR)
    | Comment!
  • Apr. 26, 2012, 6:10 PM
    Orthofix International (OFIX): Q1 EPS of $0.69 beats by $0.03. Revenue of $143.1M (+2.9% Y/Y) in-line. (PR)
    | Comment!
  • Feb. 23, 2012, 5:35 PM
    Orthofix International (OFIX): Q4 EPS of $0.80 beats by $0.07. Revenue of $151M (+5.4% Y/Y) in-line. (PR)
    | Comment!
  • Jan. 10, 2012, 12:18 PM
    Dutch orthopedic products maker Orthofix (OFIX +4.8%) jumps after reporting preliminary Q4 sales of $151.3M (+5% Y/Y), beating consensus by $0.9M. The company also says it's partnering with MTF to develop and commercialize technology for bone-grafting applications.
    | Comment!
Visit Seeking Alpha's
OFIX vs. ETF Alternatives
Company Description
Orthofix International NV is a diversified, medical device company. The Company is engaged in developing and delivering repair and regenerative solutions to the spine and orthopedic markets.